Renodapt s 360

  • Home
  • Renodapt s 360
Renodapt S 360 Product Image

Rs.1,279.00

Renodapt S 360

(10 customer reviews)

Renodapt S 360, developed by Eris, contains Mycophenolic Acid 360mg. It is an immunosuppressant medication used to prevent organ rejection in transplant patients. By suppressing the immune system, it helps reduce the likelihood of the body rejecting the transplanted organ. This formulation is designed to provide effective and reliable protection post-transplant.

Brand: Eris Composition: Mycophenolic Acid 360mg

Product Introduction

Renodapt S 360 is a trusted immunosuppressive agent used to prevent rejection in organ transplant recipients. Its active ingredient, Mycophenolic Acid, works by inhibiting immune responses that may lead to organ rejection, thereby ensuring better graft survival and patient outcomes.

This medication plays a crucial role in post-transplant care by helping to maintain the functionality of transplanted organs. Renodapt S 360 is a vital component of immunosuppressive therapy regimens.

Uses of Renodapt S 360

Renodapt S 360 is primarily used for:

Renodapt S 360 Uses
  • Organ Transplantation – Prevents rejection of kidney, liver, and heart transplants.
  • Combination Therapy – Often used alongside corticosteroids and calcineurin inhibitors.
  • Enhanced Graft Survival – Ensures long-term organ functionality and health.

Renodapt S 360 supports transplant patients by providing reliable immunosuppressive effects.

Side Effects of Renodapt S 360

Common side effects of Renodapt S 360 may include:

  • Diarrhea
  • Nausea
  • Vomiting
  • Abdominal pain
  • Headache

Less Common Side Effects

Less frequent but more serious side effects may include:

  • Increased susceptibility to infections
  • Blood disorders
  • Severe gastrointestinal complications
  • Liver enzyme abnormalities

We are pleased to offer you this product.

Renodapt S 360 is a critical medication for transplant patients, ensuring successful outcomes when used under proper medical supervision.

  • Take as prescribed by your healthcare provider, usually twice daily.
  • Swallow tablets whole; do not crush or chew.
  • Follow your doctor’s advice for regular blood tests to monitor medication levels and organ function.

Renodapt S 360 works by inhibiting inosine monophosphate dehydrogenase (IMPDH), an enzyme crucial for DNA synthesis in immune cells. This reduces the proliferation of lymphocytes, minimizing the immune response that can lead to organ rejection.

  • Reduces risk of organ rejection.
  • Enhances graft survival rates.
  • Well-tolerated with predictable pharmacokinetics.
  • Effective in combination therapy.
  • Avoid live vaccines while on this medication.
  • Monitor blood counts and kidney function regularly.
  • Use effective contraception during treatment and for 6 weeks after stopping.
  • Consult your doctor immediately if you experience severe infections or unusual bleeding.

Renodapt S 360 ensures optimal post-transplant outcomes. Always adhere to your doctor’s recommendations for best results.